Serum YKL-40 is associated with the severity of coronary artery disease and hypertension

Serum YKL-40 is associated with the severity of coronary artery disease and hypertension

Bibliographic Details
Main Authors:	Yu Xing, Jingtao Guo, Luyue Gai, Bo Liu, Donglei Luo
Format:	Article
Language:	English
Published:	Elsevier 2020-11-01
Series:	Asian Journal of Surgery
Subjects:	Coronary artery disease YKL-40 SYNTAX score
Online Access:	http://www.sciencedirect.com/science/article/pii/S1015958420302876

Similar Items

Potential association between coronary artery disease and the inflammatory biomarker YKL-40 in asymptomatic patients with type 2 diabetes mellitus
by: Kim Hyun, et al.
Published: (2012-07-01)

Prognosis and Reclassification by YKL‐40 in Stable Coronary Artery Disease
by: Jakob Schroder, et al.
Published: (2020-03-01)

Serum YKL-40 in patients with psoriasis vulgaris treated by narrow-band UVB phototherapy
by: Mohammed Abu El-Hamd, et al.
Published: (2019-08-01)

SERUM YKL-40 LEVELS IN CHRONIC HEART FAILURE.
by: Maria Kazakova, et al.
Published: (2014-06-01)

Gestasyonel Diyabetes Mellituslu Gebelerde Serum YKL-40 Düzeyi
by: Mahmut Oncul, et al.
Published: (2022-03-01)

A Comparative Study Of Lamps And Ykl-40 Tissue Expression In Glial Tumors
by: Kazakova Maria Hr., et al.
Published: (2014-09-01)

YKL-40 IN SERA OF BREAST TUMOR PATIENTS
by: Maria Kazakova, et al.
Published: (2010-07-01)

Serum YKL-40 levels and disease characteristics in patients with rheumatoid arthritis
by: Mohammad Reza Jafari-Nakhjavani, et al.
Published: (2019-01-01)

The value of YKL-40 in ischemic heart disease patients
by: Doaa S.E Zaky, et al.
Published: (2016-01-01)

Study of serum YKL-40 in children with bronchial
by: Iman A. Mohammed, et al.
Published: (2016-03-01)

YKL-40 levels are associated with disease severity and prognosis of viral pneumonia, but not available in bacterial pneumonia in children
by: Xingge Yang, et al.
Published: (2018-12-01)

YKL-40 in high-grade glioma: Prognostic value of protein versus mRNA expression
by: Yu-Hang Zhao, et al.
Published: (2018-01-01)

YKL-40 as a Potential Biomarker for the Differential Diagnosis of Alzheimer’s Disease
by: Ioannis Mavroudis, et al.
Published: (2021-12-01)

YKL-40 and cytokines - a New Diagnostic Constellation in Rheumatoid Arthritis?
by: Kazakova Maria H., et al.
Published: (2017-03-01)

YKL-40 and the Cellular Metabolic Profile in Parkinson’s Disease
by: Maria Gevezova, et al.
Published: (2023-11-01)

A novel biomarker in acute cholecystitis: YKL-40
by: Eray Çeliktürk, et al.
Published: (2023-04-01)

Elevated serum YKL40 level is a predictor of MACE during the long-term follow up in hypertensive patients
by: Mustafa Çetin, et al.
Published: (2020-04-01)

Overexpression of chitinase like protein YKL-40 in leukemia patients
by: Anil K. Hurmale, et al.
Published: (2013-01-01)

Serum YKL-40 as a potential biomarker of inflammation in psoriasis
by: Anna Baran, et al.
Published: (2018-01-01)

Increased immunohistochemical expression of YKL-40 in the spleen of patients with portal hypertension
by: Dong Wang, et al.
Published: (2012-03-01)

Comparative effects of oral hypoglycemic drugs on serum YKL-40 level in type 2 diabetic patients.
by: Caterine N. Matta*, et al.
Published: (2020-07-01)

Evaluation of the Effect of Oral Isotretinoin on the Level of Serum YKL40 in Acne Vulgaris Patients: A Cross-Sectional Case-Control
by: Ali MA, et al.
Published: (2023-11-01)

Estimation of YKL-40 acute-phase protein in serum of patients with periodontal disease and healthy individuals: A clinical-biochemical study
by: Vinay Chavan, et al.
Published: (2019-01-01)

Effect of laparoscopic splenectomy on portal vein thrombosis and serum YKL-40 in patients with cirrhotic portal hypertension
by: Ruizhao Qi, et al.
Published: (2019-11-01)

YKL-40 – A NEW DIAGNOSTIC BIOMARCER FOR BENIGN BREAST DISEASES AND BREAST CANCER
by: Vanya Uzunova, et al.
Published: (2010-07-01)

Prognostic Impact of YKL-40 Immunohistochemical Expression in Patients with Colorectal Cancer
by: Il Hwan Oh, et al.
Published: (2021-08-01)

Conserved YKL-40 changes in mice and humans after postoperative delirium
by: Jennifer David-Bercholz, et al.
Published: (2022-12-01)

Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40
by: Camilla Bjørnbak Holst, et al.
Published: (2020-04-01)

Strong YKL-40 expression in the invasive tumor front of colorectal cancer–A pilot study
by: Maria Kazakova, et al.
Published: (2024-03-01)

YKL-40 Aggravates Early-Stage Atherosclerosis by Inhibiting Macrophage Apoptosis in an Aven-dependent Way
by: Wei Huan, et al.
Published: (2021-12-01)

The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review
by: Tong X, et al.
Published: (2018-01-01)

Serum YKL-40 Levels and White Matter Hyperintensities in Patients with Acute Ischemic Stroke
by: Shi G, et al.
Published: (2023-01-01)

Serum levels of IL-6, TNF-α, and YKL-40 in patients with stage I multiple myeloma
by: Zeinab Esmaeilzadeh, et al.
Published: (2020-06-01)

Cerebrospinal fluid YKL‐40 level evolution is associated with autoimmune encephalitis remission
by: Guillaume Dorcet, et al.
Published: (2023-01-01)

Evaluation of pleural fluid YKL-40 as a marker of malignant pleural effusion
by: Adel Attia, et al.
Published: (2015-04-01)

YKL-40 Gene Expression and Plasma Levels of CD30 are not Affected by Isoflurane or Propofol: Pilot Study
by: Shirin Lak, et al.
Published: (2016-10-01)

Insulin treatment corrects hepcidin but not YKL-40 levels in persons with type 2 diabetes mellitus matched by body mass index, waist-to-height ratio, C-reactive protein and Creatinine
by: Driton Vela, et al.
Published: (2017-08-01)

Serum YKL-40 Levels in Patients with Asthma or COPD: A Pilot Study
by: Romana Olivia Popețiu, et al.
Published: (2023-02-01)

The Relationship Between Serum YKL-40 Levels on Admission and Stroke-Associated Pneumonia in Patients with Acute Ischemic Stroke
by: Shi G, et al.
Published: (2021-09-01)

Serum YKL-40 Levels Predict Endotypes and Associate with Postoperative Recurrence in Patients with Chronic Rhinosinusitis with Nasal Polyps
by: Wen S, et al.
Published: (2021-10-01)